🔎 Trials Near Me

Home › Soft Tissue Sarcoma › California › San Francisco

Soft Tissue Sarcoma clinical trials in San Francisco, CA

5 studies for Soft Tissue Sarcoma are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

RecruitingPhase 1
  • University of California, San Francisco (UCSF), San Francisco
Ages 12 to 85 · All sexes · Updated Sep 8, 2026 · NCT03715933

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

RecruitingPhase 1
  • University of California San Francisco, San Francisco
Ages 5 to 40 · All sexes · Updated Sep 3, 2026 · NCT06156410

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

RecruitingPhase 1/2
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT06975293

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Recruiting
  • Zuckerberg San Francisco General, San Francisco
  • Kaiser Foundation Research Institute, San Francisco
  • University of San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT05297734

Prospective Registry of Histotripsy for Soft Tissue Tumors

RecruitingObservational study
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT07470008

About Soft Tissue Sarcoma

Soft tissue sarcoma refers to cancer that begins in the muscle, fat, vessels or tendons. It can cause a lump or swelling. See which treatments are available

More about Soft Tissue Sarcoma on MedlinePlus

Soft Tissue Sarcoma trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.